Article

Photocoagulator gets FDA marketing OK

Santa Clara, CA—Lumenis Ltd. has received FDA clearance to market its Novus 3000, a 532 nm diode-pumped solid-state (DPSS) photocoagulator.

Santa Clara, CA-Lumenis Ltd. has received FDA clearance to market its Novus 3000, a 532 nm diode-pumped solid-state (DPSS) photocoagulator.

The new product is an improved version of its Novus 2000, which has about 1,500 units installed worldwide. The device offers up to 3 watts of power through semiconductor-based technology, and has a color touch-screen interface and liquid crystal display remote control for instant adjustments to treatment parameters. Novus 3000 features built-in storage for a laser indirect ophthalmoscope, remote control, foot switch, and other accessories.

Multiple memory locations allow ophthalmologists to save and recall preferences, and two dedicated illumination sources expand treatment options. Two delivery devices can be attached at once for switching during procedures.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.